These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2330762

  • 1. [Effect of kidney occlusion on survival in renal cell carcinoma: a 10-year retrospective study].
    Latal D, Kautzky W, Wanek R, Kumpan W.
    Z Urol Nephrol; 1990 Jan; 83(1):27-31. PubMed ID: 2330762
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Results of endovascular interventions (embolization and chemoembolization) in the treatment of operable and extensive kidney cancer].
    Granov AM, Gorelov AI, Gershanovich ML, Karelin MI, Vorob'ev AV, Filov VA, Stukov AN.
    Vopr Onkol; 1998 Jan; 44(6):711-4. PubMed ID: 10087971
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
    Bergerat JP, Ford J, Herbrecht R, Dufour P, Oberling F, Jacqmin D, Bollack C, Prevot G, Salze P, Jurascheck F.
    Prog Clin Biol Res; 1990 Jan; 348():137-50. PubMed ID: 2385604
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Embolization of renal carcinoma. Comparison between the early results of Gelfoam and absolute ethanol embolization.
    Leinonen A.
    Ann Clin Res; 1985 Jan; 17(6):299-305. PubMed ID: 3913377
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Embolization for renal carcinoma].
    Li S, Dong Z, Li J.
    Zhonghua Wai Ke Za Zhi; 1998 Feb; 36(2):101-2. PubMed ID: 11715549
    [Abstract] [Full Text] [Related]

  • 13. [A clinical study of renal cell carcinoma].
    Uchida T, Izumi H, Kobayashi K, Arakawa T, Honda N, Omata T, Odajima K, Mashimo S, Endo T, Ishibashi A.
    Hinyokika Kiyo; 1985 Nov; 31(11):1919-25. PubMed ID: 4091134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Surgery of metastatic renal cell carcinoma and use of renal infarction.
    Swanson DA, Wallace S.
    Semin Surg Oncol; 1988 Nov; 4(2):124-8. PubMed ID: 3293153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CG.
    Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
    Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, Belldegrun A.
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.